A review by the US Office of Inspector General found that only about half of the scientists running clinical trials funded by the NIH in 2019 and 2020 appropriately recorded their findings in a federal database, as is legally required.

Too often, studies that aim to develop new treatments for patients fail to adequately cite and build upon research that preceded them.

The ACTIV-6 trial reports that people who took the drug for three days may have spent slightly less time feeling unwell with SARS-CoV-2, but fails to find differences in disease progression between the treatment and placebo groups.

How scientists aim to induce an immune response against addictive drugs

Researchers are turning to the immune system for help in treating addiction and preventing overdose.

Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?

The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug.

Researchers are revealing the complexity of the microbial community living on the body—and paving the way for new bacteria-targeting treatments for acne and other dermatological conditions.

Some experts argue that better trials are needed before putting interventions into practice.

Beaumanoir helped Jews evade Nazis during World War II and aided resistance fighters during the Algerian War of Independence. She also contributed to the field of epileptology.

Ukrainian scientists and universities face extraordinary challenges as the Russian invasion continues.

A new wave of research is recruiting patients and other members of the public to serve as equal partners, bringing fresh perspectives to research on diseases and other conditions.

A new regulation and registry covering investigational medicinal products mandates reporting and supports multinational trials.